Company intelligence / Profile preview

Delphinus Medical Technologies

Novi, Michigan, United Statesdelphinusmt.com ↗

Ownership: Private
Employees: ~55
Development stage: Commercial

Overview

Delphinus’ SoftVue system has received FDA approval as an adjunct to mammography for breast cancer screening in women with dense breasts. Clinical studies have shown that when paired with mammography, SoftVue identifies up to 20–25% more cancers while reducing unnecessary callbacks and biopsies compared to mammography alone. The device does not use radiation or compression and images the entire breast in a single scan.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Medical Imaging

Partnerships

Premier Inc. – national group purchasing agreement and Technology Breakthrough designationWest Jefferson Medical Center (SoftVue installation/use)McLeod Regional Medical Center (SoftVue installation/use)UR Medicine (SoftVue installation/use)East Alabama Medical Center (SoftVue installation/use)

Beyond the preview

Go deeper on Delphinus Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delphinus Medical Technologies.

Explore the full profile